Suppr超能文献

脓毒性休克中的去甲肾上腺素:何时用?用多少?

Norepinephrine in septic shock: when and how much?

机构信息

aHôpitaux universitaires Paris-Sud, Hôpital Antoine Béclère, service de réanimation polyvalente, Clamart, France bDepartment of Anaesthesiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands cHôpitaux universitaires Paris-Sud, Hôpital de Bicêtre, service de réanimation médicale dINSERM UMR S_999, Univ Paris-Sud, Le Kremlin-Bicêtre, France.

出版信息

Curr Opin Crit Care. 2017 Aug;23(4):342-347. doi: 10.1097/MCC.0000000000000418.

Abstract

PURPOSE OF REVIEW

Norepinephrine is the first-line agent recommended during resuscitation of septic shock to correct hypotension due to depressed vascular tone. Important clinical issues are the best timing to start norepinephrine, the optimal blood pressure target, and the best therapeutic options to face refractory hypotension when high doses of norepinephrine are required to reach the target.

RECENT FINDINGS

Recent literature has reported benefits of early administration of norepinephrine because of the following reasons: profound and durable hypotension is an independent factor of increased mortality, early administration of norepinephrine increases cardiac output, improves microcirculation and avoids fluid overload. Recent data are in favor of targeting a mean arterial pressure of at least 65 mmHg and higher values in case of chronic hypertension. When hypotension is refractory to norepinephrine, it is recommended adding vasopressin, which is relatively deficient during sepsis and acts on other vascular receptors than α1-adernergic receptors. However, increasing the dose of norepinephrine further cannot be discouraged.

SUMMARY

Early administration of norepinephrine is beneficial for septic shock patients to restore organ perfusion. The mean arterial pressure target should be individualized. Adding vasopressin is recommended in case of shock refractory to norepinephrine.

摘要

目的综述

去甲肾上腺素是推荐用于纠正因血管张力降低引起的感染性休克低血压的一线药物。重要的临床问题是何时开始使用去甲肾上腺素的最佳时机、最佳血压目标,以及当需要大剂量去甲肾上腺素达到目标时,面对难治性低血压的最佳治疗选择。

最近的发现

最近的文献报道了早期使用去甲肾上腺素的益处,原因如下:严重且持久的低血压是增加死亡率的独立因素,早期使用去甲肾上腺素增加心输出量,改善微循环并避免液体过载。最近的数据倾向于将平均动脉压目标至少设定为 65mmHg,在慢性高血压的情况下设定更高的值。当去甲肾上腺素难治性低血压时,建议添加血管加压素,在脓毒症期间血管加压素相对缺乏,并且作用于与α1-肾上腺素受体不同的其他血管受体。然而,不应劝阻进一步增加去甲肾上腺素的剂量。

总结

早期使用去甲肾上腺素有益于感染性休克患者恢复器官灌注。平均动脉压目标应个体化。在去甲肾上腺素难治性休克的情况下,建议添加血管加压素。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验